Immediate Impact

57 standout
Sub-graph 1 of 24

Citing Papers

Advances in covalent drug discovery
2022 Standout
Sickle Cell Disease
2022 Standout
3 intermediate papers

Works of Erin E. O’Branski being referenced

Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group.
1999
Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell disease
1997

Author Peers

Author Last Decade Papers Cites
Erin E. O’Branski 418 349 113 6 501
Nermeen Varawalla 436 333 113 10 509
JULIAN R. DAVIS 384 304 89 7 456
Aphrodite Loutradi 442 307 94 13 536
G P Rodgers 447 334 157 7 510
Livia Robbiolo 328 286 41 6 492
Paola Tonucci 376 327 137 8 530
C Hesketh 298 229 53 7 420
R. P. Perrine 518 400 150 8 562
José Villagra 227 229 25 6 492
Suzy Maria Teresa Durazzi 359 403 177 7 556

All Works

Loading papers...

Rankless by CCL
2026